Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (81-90 of 784) with videos related to

Pageof 79
Sort By:
European Journal of Preventive Cardiology|July 23, 2021
A scoring system for predicting individual treatment effects of statins in type 2 diabetes patients on haemodialysisBernd Genser, Christoph Wanner, Winfried März
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2022
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Clinical Transplantation|February 17, 2007
Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantationKai Lopau, Alexandra Greser, Christoph Wanner
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 3, 2007
Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular riskChristoph Wanner, Christiane Drechsler, Vera Krane
Journal of the American Society of Nephrology : JASN|July 11, 2006
Cross-talk between the kidney and the cardiovascular systemKerstin Amann, Christoph Wanner, Eberhard Ritz
European Journal of Preventive Cardiology|August 23, 2022
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Kidney International|February 22, 2022
The safety and feasibility of incremental dialysis must be proven before its widespread useChristoph Wanner, Kai Lopau, Henrike Haberstroh
Seminars in Dialysis|August 28, 2009
C-reactive protein and uremiaChristoph Wanner, Christiane Drechsler, Vera Krane
Deutsche Medizinische Wochenschrift (1946)|May 11, 2022
[Safety and effectiveness of oral anticoagulation in patients with atrial fibrillation and renal insufficiency - a real-world perspective]Uwe Zeymer, Hendrik Bonnemeier, Christoph Wanner
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Kidney as pacemaker for cardiovascular aging]Christoph Wanner, Jan Galle, Kai Lopau
Pageof 79

Showing results (81-90 of 784) with videos related to

Sort By:
Pageof 79
European Journal of Preventive Cardiology|July 23, 2021
A scoring system for predicting individual treatment effects of statins in type 2 diabetes patients on haemodialysisBernd Genser, Christoph Wanner, Winfried März
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2022
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Clinical Transplantation|February 17, 2007
Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantationKai Lopau, Alexandra Greser, Christoph Wanner
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 3, 2007
Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular riskChristoph Wanner, Christiane Drechsler, Vera Krane
Journal of the American Society of Nephrology : JASN|July 11, 2006
Cross-talk between the kidney and the cardiovascular systemKerstin Amann, Christoph Wanner, Eberhard Ritz
European Journal of Preventive Cardiology|August 23, 2022
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal AssociationAlberto Ortiz, Christoph Wanner, Ron Gansevoort, et al.
Kidney International|February 22, 2022
The safety and feasibility of incremental dialysis must be proven before its widespread useChristoph Wanner, Kai Lopau, Henrike Haberstroh
Seminars in Dialysis|August 28, 2009
C-reactive protein and uremiaChristoph Wanner, Christiane Drechsler, Vera Krane
Deutsche Medizinische Wochenschrift (1946)|May 11, 2022
[Safety and effectiveness of oral anticoagulation in patients with atrial fibrillation and renal insufficiency - a real-world perspective]Uwe Zeymer, Hendrik Bonnemeier, Christoph Wanner
Deutsche Medizinische Wochenschrift (1946)|March 1, 2021
[Kidney as pacemaker for cardiovascular aging]Christoph Wanner, Jan Galle, Kai Lopau
Pageof 79